Connection
Frederick Masoudi to Thiazolidinediones
This is a "connection" page, showing publications Frederick Masoudi has written about Thiazolidinediones.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.948 |
|
|
|
-
Masoudi FA. Improving drug safety surveillance: lessons from rosiglitazone. Circ Cardiovasc Qual Outcomes. 2010 Sep; 3(5):444-6.
Score: 0.303
-
Lindenfeld J, Masoudi FA. Fluid retention with thiazolidinediones: does the mechanism influence the outcome? J Am Coll Cardiol. 2007 Apr 24; 49(16):1705-7.
Score: 0.240
-
Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation. 2005 Feb 08; 111(5):583-90.
Score: 0.207
-
Masoudi FA, Wang Y, Inzucchi SE, Setaro JF, Havranek EP, Foody JM, Krumholz HM. Metformin and thiazolidinedione use in Medicare patients with heart failure. JAMA. 2003 Jul 02; 290(1):81-5.
Score: 0.185
-
Inzucchi SE, Masoudi FA, Wang Y, Kosiborod M, Foody JM, Setaro JF, Havranek EP, Krumholz HM. Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project. Diabetes Care. 2005 Jul; 28(7):1680-9.
Score: 0.013